Literature DB >> 10411280

Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2.

E Mocchegiani1, L Perissin, L Santarelli, A Tibaldi, S Zorzet, V Rapozzi, R Giacconi, D Bulian, T Giraldi.   

Abstract

Melatonin (MEL) may counteract tumors through a direct oncostatic role. MEL is also an antistress agent with immunoenhancing properties against tumors due to a suppressive role of MEL on corticosterone release. Rotational stress (RS) (spatial disorientation) facilitates metastasis progression in mice. Also, MEL counteracts tumors because of its influence on immune responses via the metabolic zinc pool, which, is reduced in tumors and stress. Zinc is required for normal thymic endocrine activity (i.e. thymulin) and interleukin-2 (IL-2) production. Because in vivo data is still controversial, exogenous MEL treatment (22 days in drinking water) in both intact and pinealectomized (px) mice bearing Lewis lung carcinoma leads to significant decrements of metastasis volume, restoration of the negative crude zinc balance, recovery of thymulin activity and increment of IL-2 exclusively in intact and px tumor bearing mice subjected to RS. Significant inverse correlations are found in both stressed intact and px tumor bearing mice after MEL treatment between zinc and corticosterone (r = 0.78, P < 0.01; r = 0.80, P < 0.01, respectively). Positive correlations between zinc and IL-2 (r = 0.75, P < 0.01; r = 0.73, P < 0.01, respectively) or thymulin (r = 0.75, P < 0.01; r = 0.82, P < 0.01, respectively) are observed in same models of mice. These findings suggest a MEL action to decrease metastasis mediated by a possible interplay between zinc and MEL, via corticosterone, with consequent restoration of thymic efficiency and IL-2 production. MEL as an antistress agent with immunoenhancing properties in cancer deserves further consideration.nuclear factor-kb; POMC, proopiomelanocortin; Px, pinealectomized mice; RIA, radioimmunoassay; RS, rotational stress; SDI, stressed intact mice; SDPx, stressed pinealectomized mice; TNF-alpha, tumor necrosis factor-alpha; ZnFTS, active zinc-bound thymulin; ZnFTS + FTS, total thymulin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411280     DOI: 10.1016/s0192-0561(98)00067-8

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  4 in total

1.  Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells.

Authors:  P Plaimee; M Khamphio; N Weerapreeyakul; S Barusrux; N P Johns
Journal:  Cell Prolif       Date:  2014-07-23       Impact factor: 6.831

Review 2.  Melatonin as a potential anticarcinogen for non-small-cell lung cancer.

Authors:  Zhiqiang Ma; Yang Yang; Chongxi Fan; Jing Han; Dongjin Wang; Shouyin Di; Wei Hu; Dong Liu; Xiaofei Li; Russel J Reiter; Xiaolong Yan
Journal:  Oncotarget       Date:  2016-07-19

3.  Leptin and zinc relation: In regulation of food intake and immunity.

Authors:  Abdulkerim Kasim Baltaci; Rasim Mogulkoc
Journal:  Indian J Endocrinol Metab       Date:  2012-12

Review 4.  Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?

Authors:  E S Schernhammer; K Schulmeister
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.